Mixed Race Studies

Amalgamation Schemes: Antiblackness and the Critique of Multiracialism

University of Minnesota Press
2008
328 pages
6 x 9
Paper ISBN: 978-0-8166-5105-4; ISBN-10: 0-8166-5105-1
Cloth ISBN: 978-0-8166-5104-7; ISBN-10: 0-8166-5104-3

Jared Sexton, Associate Professor of African American Studies and Film & Media Studies
University of California, Irvine

Questions the ramifications of multiracialism for progressive social change.

Despite being heralded as the answer to racial conflict in the post–civil rights United States, the principal political effect of multiracialism is neither a challenge to the ideology of white supremacy nor a defiance of sexual racism. More accurately, Jared Sexton argues in Amalgamation Schemes, multiracialism displaces both by evoking long-standing tenets of antiblackness and prescriptions for normative sexuality.

In this timely and penetrating analysis, Sexton pursues a critique of contemporary multiracialism, from the splintered political initiatives of the multiracial movement to the academic field of multiracial studies, to the melodramatic media declarations about “the browning of America.” He contests the rationales of colorblindness and multiracial exceptionalism and the promotion of a repackaged family values platform in order to demonstrate that the true target of multiracialism is the singularity of blackness as a social identity, a political organizing principle, and an object of desire. From this vantage, Sexton interrogates the trivialization of sexual violence under chattel slavery and the convoluted relationship between racial and sexual politics in the new multiracial consciousness.

An original and challenging intervention, Amalgamation Schemes posits that multiracialism stems from the conservative and reactionary forces determined to undo the gains of the modern civil rights movement and dismantle radical black and feminist politics.

Table of Contents

• Introduction: On the Verge of Race
• 1. Beyond the Event Horizon: The Multiracial Project
• 2. Scales of Coercion and Consent: Sexual Violence, Antimiscegenation, and the Limits of Multiracial America
• 3. There Is No (Interracial) Sexual Relationship
• 4. The Consequence of Race Mixture
• 5. The True Names of Race: Blackness and Antiblackness in Global Contexts
• Notes
• Works Cited
• Index

Racial Medicine: Not So Fast

The Daily Beast
2008-08-19

Sharon Begley, Senior Health and Science Correspondent
Reuters

Next time you want to start a bar fight, proclaim to everyone within earshot that “race is not real; it is just a social and cultural construct and has no biological validity.” Then duck before you get punched in the face. . . . but as you’re avoiding injury try to hand your would-be assailants a new paper published online this afternoon by the journal Clinical Pharmacology & Therapeutics, which concludes that classifying people by the crude category of race—as in, of African, Asian or European ancestry—for medical purposes, as some people want to do, is really, really stupid…

…Which brings us to the new study. Scientists at the J. Craig Venter Institute got the cool idea of analyzing the genomes of two white guys who, according to the conventional racial categories, belong to the same race. The two are Venter himself and James Watson, co-discoverer of the double-helix structure of DNA. Venter led the private effort to sequence the human genome, winding up in a tie with the public project to do the same.

It happens that the genomes of both men are in the public domain. Watson agreed to have his sequenced and published last year, with Venter right behind. So what do the genomes reveal?

The two men metabolize drugs, including antidepressants, codeine, antipsychotics and the cancer drug tamoxifen, differently. Venter has two functional copies of the CYP2D6 form of the cytochrome P-450 gene, which metabolizes more than 75 percent of drugs, while Watson has two copies of the more-sluggish variant of the gene. That’s rare for Caucasians (only 3 percent of whites have the sluggish version), but common in East Asians (49 percent of whom have it). Funny, Watson doesn’t look Chinese. But if Watson’s doctor decided to use race-based medicine to predict how he would metabolize drugs, she’d say, well, we have a white guy here, and whites rarely have the sluggish version, so I’ll assume Watson doesn’t have it either. As a result, the drug would stay in Watson’s system longer, with stronger effects compared to someone in whom the drug was quickly metabolized and cleared from the body. “It is unlikely that a doctor would guess that optimal drug dosages might differ for Drs. Watson and Venter,” the scientists write.

That’s why Venter and colleagues conclude that race is too crude a proxy for what genetic group—ethnicity or, as biologists say, population—someone belongs to. It is imperative to “go beyond simplistic ethnic categorization,” they write, since that can be seriously—and perhaps fatally—misleading. (In the U.S., some 100,000 people a year die of adverse drug reactions, many caused by an inability to properly metabolize the medication because of a particular CYP2D6 variation.) “Race/ethnicity should be considered only a makeshift solution for personalized genomics because it is too approximate,” they write…

Read the entire article here.